Cadila Healthcare

Indian multinational pharmaceutical company

Cadila Healthcare ▸ Facts ▸ Comments ▸ News ▸ Videos

Cadila Healthcare Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020.

0 shares	Share Tweet Save Post Send


What is Virafin? How does the Zydus Cadila drug work? \| Oneindia News Zydus Cadila's Virafin has been approved for emergency use to treat moderate Covid-19 patients by the drug controller general of india. How does Virafin work? #Virafin #ZydusCadila #CovidDrug Credit: Oneindia Duration: 01:24Published 2 weeks ago


Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by.. Credit: ANI Duration: 02:01Published 2 weeks ago

You Might Like

Zydus Cadila's Virafin granted restricted emergency use approval for treating Covid patients: DBT IndiaTimes - Published 2 weeks agoAlso reported by •DNA
Zydus Cadila Healthcare starts producing Covid-19 vaccine IndiaTimes - Published 2 weeks ago
Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatment Drug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate.. IndiaTimes - Published 2 weeks ago

Zydus vaccine to cover children too IndiaTimes - Published 3 weeks ago
Companies set to double Remdesivir output Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which.. IndiaTimes - Published on April 13, 2021
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine IndiaTimes - Published on January 3, 2021

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1 Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an.. IndiaTimes - Published on December 7, 2020
Covid-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy IndiaTimes - Published on December 4, 2020
Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad. After.. IndiaTimes - Published on November 28, 2020
PM Modi reaches Ahmedabad to review coronavirus vaccine development Prime Minister Narendra Modi landed here on Saturday as part of his three-city visit to ireview coronavirus vaccine development work at facilities there, an official said. From the airport, Modi.. IndiaTimes - Published on November 28, 2020

PM to visit Zydus' Covid-19 vaccine development centre in Gujarat IndiaTimes - Published on November 27, 2020
PM to visit vaccine centres in 3 cities While in Hyderabad, the PM will visit vaccine maker Bharat Biotech’s facilities, where work on the development of India’s first indigenous Covid-19 vaccine, Covaxin, is under way, he will drop in.. IndiaTimes - Published on November 26, 2020
India to get COVID-19 vaccine by mid-2021, says Biocon's Kiran Mazumdar-Shaw Besides, Bharat Biotech, Zydus Cadila Ltd is also in Phase 2 of human clinical trials of a COVID-19 vaccine. DNA - Published on October 24, 2020	For high-risk groups, government plans to fast-track vaccine India has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum Institute is ahead and is set to enter phase 3... IndiaTimes - Published on September 13, 2020
Covid-19 vaccine: Govt panel meets representatives of leading domestic manufacturers The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum Institute of India, Bharat Biotech and Zydus Cadila, on Monday to.. IndiaTimes - Published on August 17, 2020	National Expert Group discusses vaccine development with domestic manufactures National Expert Group on Vaccine Administration on Monday met leading domestic vaccine manufactures- Serum Institute of India, Pune; Bharat Biotech, Hyderabad; Zydus Cadila, Ahmedabad; Gennova.. DNA - Published on August 17, 2020
Zydus' 'budget' injection costs 2,800/shot Ahmedabad-based Zydus Cadila announced the launch of its anti-viral Remdesivir drug at Rs 2,800 per injection, making it the "most economical" brand in the country. IndiaTimes - Published on August 14, 2020	COVID-19: Drug firm Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 Yet again, India witnessed the highest-ever single-day spike of 66,999 new COVID-19 cases the last 24 hours. DNA - Published on August 13, 2020
Zydus Cadila gets USFDA nod for drug trials to treat chemotherapy-induced anemia In a regulatory filing, Zydus Cadila said it has received approval from the US Food and Drug Administration (USFDA) to initiate clinical trials of Desidustat in CIA. Zydus Cadila Chairman Pankaj R.. IndiaTimes - Published on July 23, 2020	Seven Indian pharma players race to develop Covid-19 vaccine At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already.. IndiaTimes - Published on July 19, 2020
Zydus Cadila starts human trials of vaccine IndiaTimes - Published on July 15, 2020	India's Zydus begins human trials for potential Covid-19 vaccine Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential Covid-19 vaccine. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and.. IndiaTimes - Published on July 15, 2020
Hyd co to start human trials on Covid vaccine soon; Cadila too gets DCGI nod for vaccine trial IndiaTimes - Published on July 3, 2020	Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the Drugs Controller General of India (DCGI) on.. IndiaTimes - Published on July 3, 2020
India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show.. Reuters India - Published on June 12, 2020	India's Zydus Cadila signs pact with Gilead to make remdesivir Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in.. Reuters India - Published on June 12, 2020

Cadila Healthcare

Indian multinational pharmaceutical company

Cadila Healthcare ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Zydus Cadila's Virafin granted restricted emergency use approval for treating Covid patients: DBT

Zydus Cadila Healthcare starts producing Covid-19 vaccine

Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatment

Zydus vaccine to cover children too

Companies set to double Remdesivir output

Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Covid-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

PM Modi reaches Ahmedabad to review coronavirus vaccine development

PM to visit Zydus' Covid-19 vaccine development centre in Gujarat

PM to visit vaccine centres in 3 cities

India to get COVID-19 vaccine by mid-2021, says Biocon's Kiran Mazumdar-Shaw

For high-risk groups, government plans to fast-track vaccine

Covid-19 vaccine: Govt panel meets representatives of leading domestic manufacturers

National Expert Group discusses vaccine development with domestic manufactures

Zydus' 'budget' injection costs 2,800/shot

COVID-19: Drug firm Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800

Zydus Cadila gets USFDA nod for drug trials to treat chemotherapy-induced anemia

Seven Indian pharma players race to develop Covid-19 vaccine

Zydus Cadila starts human trials of vaccine

India's Zydus begins human trials for potential Covid-19 vaccine

Hyd co to start human trials on Covid vaccine soon; Cadila too gets DCGI nod for vaccine trial

Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir

India's Zydus Cadila signs pact with Gilead to make remdesivir